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Abstract
OBJECTIVE—To evaluate trends of monozygotic twinning after single embryo transfer and its 
association with patient and treatment factors.
METHODS—Our retrospective cohort study included 28,596 pregnancies after fresh, nondonor 
single embryo transfer during 2003–2012 reported to the National ART Surveillance System. We 
examined trends of monozygotic twin pregnancies (number of fetal heart tones on first-trimester 
ultrasonography more than one or number of neonates born more than one) and assessed patient 
and treatment factors for monozygotic twin compared with singleton pregnancies. Modified 
Poisson regression models were used to estimate adjusted risk ratios (RRs) and 95% confidence 
intervals (CIs) for association between monozygotic twinning and selected factors stratified by 
day 2–3 and day 5–6 transfer.
RESULTS—During 2003–2012, the incidence of monozygotic twinning after single embryo 
transfer was lower for day 2–3 transfers than for day 5–6 transfers (1.71%, 95% CI 1.45–1.98, 
n=162 compared with 2.50%, 95% CI 2.28–2.73, n=472); the incidence did not change 
significantly over the study period. Among day 2–3 transfers, assisted hatching increased the risk 
for monozygotic twinning compared with singletons (adjusted RR 2.16, 95% CI 1.53–3.06); use of 
intracytoplasmic sperm injection decreased the risk (adjusted RR 0.60, 95% CI 0.42–0.85). 
Having one or more prior pregnancies increased the risk for monozygotic twinning among day 5–
6 transfers (adjusted RR 1.26, 95% CI 1.03–1.53).
CONCLUSION—Monozygotic twinning after single embryo transfers was more common among 
day 5–6 embryo transfers than day 2–3 transfers. Use of assisted hatching was associated with 
increased risk for monozygotic twinning for day 2–3 transfers.
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Multiple gestation pregnancies are associated with higher risk of maternal and fetal 
morbidity and mortality compared with singleton gestation,1 and population twinning 
incidence has increased 76% over the past three decades.2,3 Although twin pregnancies after 
in vitro fertilization (IVF) are primarily dizygotic, there is also an increased incidence of 
monozygotic twins from two to 12 times the population incidence of 0.4%.4–6 As compared 
with dizygotic twins, monozygotic twins have a higher risk of complications and poor 
outcomes.4
As a result of low monozygotic twinning incidence, studies evaluating proposed risk factors 
are frequently underpowered or contradictory.5,7–13 The Centers for Disease Control and 
Prevention’s National ART Surveillance System, a nationally mandated surveillance system 
containing information about United States assisted reproductive technology (ART) cycles, 
is large enough to examine these factors. Although previous population-based studies 
assessed the risks of monozygotic twinning,13–15 the prevalence of blastocyst transfer, a risk 
factor for monozygotic twinning,13,15 has increased over time, particularly among single 
embryo transfers.16 Furthermore, findings from earlier studies may be subject to 
misclassification bias as a result of the indirect calculation of zygosity, particularly when 
more than one embryo was transferred.14,15
In the current study, we aim to quantify trends in monozygotic twinning after single embryo 
transfer in the United States from 2003 to 2012 and to identify risk factors for monozygotic 
twinning among women undergoing IVF stratified by day of transfer.
MATERIALS AND METHODS
The Fertility Clinic Success Rates and Certification Act of 1992 requires that every ART 
program annually report data about all ART procedures to the Centers for Disease Control 
and Prevention.17 These data are transmitted to the Centers for Disease Control and 
Prevention’s National ART Surveillance System and are used to produce an annual report 
containing clinic-specific and national pregnancy success rates. In the National ART 
Surveillance System, an ART cycle is defined as fertility treatments in which eggs and 
sperm or embryos are handled for the purpose of establishing a pregnancy. These data 
contain one record per cycle; multiple cycles from an individual patient are not linked. The 
Centers for Disease Control and Prevention estimates that the National ART Surveillance 
System includes more than 95% of all ART cycles performed in the United States.18
We selected data from reporting years 2003–2012 for this retrospective cohort study. Data 
were restricted to fresh, nondonor IVF cycles in which one embryo was transferred and 
resulted in clinical intrauterine pregnancy. Cycles with missing information on the number 
of embryos transferred to the uterus, number of fetal heart tones at first-trimester 
ultrasonogram, or maternal age were excluded (n=211). Because we determined a priori that 
day of embryo transfer was likely to be an important effect-measure modifier, cycles with 
embryo transfers occurring on days other than 2–3 (cleavage stage) or 5–6 (blastocyst stage) 
were also excluded (2.3%) because they could not be accurately categorized as either 
cleavage or blastocyst stage.
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Pregnancies containing a monozygotic pair were defined as those in which more than one 
fetal heart tone was reported at the first-trimester ultrasonogram or those in which the 
number of liveborn or stillborn neonates was more than one. The comparison group was 
composed of singleton pregnancies. The number of gestational sacs is not reported for 
clinical pregnancies; therefore, we were unable to account for twin clinical pregnancies 
(having two gestational sacs) where only one heartbeat was reported at first-trimester 
ultrasonography or only one neonate was liveborn or stillborn.
We calculated the incidence of monozygotic twinning for 2-year intervals among all 
pregnancies reported during 2003–2012 that resulted from fresh, nondonor single embryo 
transfers; we also assessed trends stratified by day of transfer (day 2–3 or 5–6) using the 
Cochrane-Armitage test. Data were grouped into 2-year intervals as a result of small 
numerators (less than 20) when individual years were considered, particularly for day 2–3 
transfers. We also examined linear trends in the absolute number of day 2–3 and day 5–6 
single embryo transfers and the absolute number of monozygotic twin pregnancies over the 
study period using ordinary least squares regression. We used two-tailed χ2 tests to compare 
the distribution of patient and cycle characteristics among the monozygotic twin pregnancy 
group and the singleton pregnancy group. We further stratified by day 2–3 and day 5–6 
transfers and used modified Poisson regression models to estimate adjusted risk ratios (RRs) 
for the association between monozygotic twinning and selected patient and cycle 
characteristics. These models were adjusted for factors that were determined a priori to be 
potential confounders: maternal age (younger than 30, 30–34, 35–39, 40 years or older), 
infertility diagnosis (tubal factor, endometriosis, uterine factor, ovulatory disorder, 
diminished ovarian reserve, male factor), number of prior pregnancies (zero, one or more), 
number of prior ART cycles (zero, one or more), number of oocytes retrieved (one to four, 
five or more), use of intracytoplasmic sperm injection, use of assisted hatching (the 
purposeful disruption of an embryo’s zona pellucida by laser, mechanical, or chemical 
means), and having one or more supernumerary embryo(s) available for cryopreservation. 
Maternal race or ethnicity was not included in the final models because more than 38% of 
values were missing; findings from a sensitivity analysis indicated that the magnitude and 
direction of results did not change significantly with and without their inclusion in the 
model. Numbers of prior spontaneous abortions and prior live births were not included in the 
adjusted models because of colinearity with number of prior pregnancies. Because both 
younger age and assisted hatching are known to increase the risk for monozygotic twinning, 
we included an interaction term for age and assisted hatching in the models; however, the 
interaction was not statistically significant and was not retained in the final models. We also 
evaluated the association between monozygotic twinning and the outcomes of interest using 
the more restrictive definition of monozygotic twinning based on liveborn and stillborn 
neonates only. The findings were not substantively different from those using the definition 
including fetal hearts and variations were largely the result of diminished sample size; thus, 
the more inclusive definition was used. P<.05 were considered statistically significant.
This research was approved by the institutional review board at the Centers for Disease 
Control and Prevention.
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We identified 28,596 pregnancies after a single embryo transfer during January 2003 to 
December 2012. Of those, 641 pregnancies contained a monozygotic pair and 27,955 were 
singleton pregnancies. When the definition of monozygotic pregnancy was restricted to the 
presence of more than one liveborn or stillborn neonate irrespective of the number of fetal 
hearts, the total number of monozygotic pregnancies was 442. The absolute number of fresh, 
nondonor single embryo transfers increased over the study period for day 2–3 and day 5–6 
transfers (Fig. 1). The overall incidence of monozygotic twinning after single embryo 
transfer during 2003–2012 was 2.24% (95% confidence interval [CI] 2.07–2.41); the 
incidence did not change over the study period (Fig. 2; P=.80). The absolute number of 
monozygotic twin pregnancies was 46, 66, 127, 169, and 233 for 2003–2004, 2005–2006, 
2007–2008, 2009–2010, and 2011–2012, respectively, and increased linearly over the study 
period (P=.001). When stratified by day of transfer, the overall incidence of monozygotic 
twinning was lower in day 2–3 transfers than in day 5–6 transfers (1.71%, 95% CI 1.45–
1.97, n=162 compared with 2.50%, 95% CI 2.28–2.73, n=472, χ2 P<.001). The incidence of 
monozygotic twinning among day 2–3 and day 5–6 transfers was also unchanged over the 
study period (Cochran-Armitage P=.95 and P=.29, respectively).
Women with monozygotic twin pregnancies had a higher frequency of ovulatory disorders 
and lower frequencies of diminished ovarian reserve and prior pregnancies than women with 
singleton pregnancies (Table 1). The monozygotic twin pregnancy group also had a higher 
proportion of prior pregnancies and day 5–6 transfers and used intracytoplasmic sperm 
injection less frequently than the singleton pregnancy group. For all variables, the amount of 
missing data was less than 0.50%.
Among day 2–3 transfers, maternal age younger than 30 years (adjusted RR 1.68, 95% CI 
1.05–2.71) and assisted hatching (adjusted RR 2.16, 95% CI 1.53–3.06) were associated 
with an increased risk of monozygotic twin pregnancy when compared with singleton 
pregnancies; use of intracytoplasmic sperm injection (adjusted RR 0.60, 95% CI 0.42–0.85) 
was associated with decreased risk (Table 2).
Among day 5–6 transfers, maternal age 35–39 years (adjusted RR 0.73, 95% CI 0.58–0.93) 
and uterine factor infertility (adjusted RR 0.50, 95% CI 0.28–0.90) were associated with a 
decreased risk for monozygotic pregnancy compared with singleton pregnancies (Table 3).
DISCUSSION
Monozygotic twinning incidence after single embryo transfer has not changed over the past 
decade and was more common among day 5–6 than day 2–3 embryo transfers. Increases in 
the number of day 5–6 single embryo transfers over time may be the result of advances in 
extended media culture,19 improvements in live birth rates after blastocyst transfer,20 and 
reductions in aneuploidy compared with cleavage-stage embryo transfers.21
Assisted hatching was associated with a twofold increased risk of monozygotic pregnancy 
among day 2–3 transfers compared with singleton pregnancy; however, no association was 
found among day 5–6 transfers. This finding is consistent with a recent study reporting an 
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interaction between assisted hatching and day of transfer in models predicting the likelihood 
of monozygotic twinning.13 Because the incidence of monozygotic twinning among day 5–6 
transfers is higher than among day 2–3 transfers, we may have been unable to detect any 
additional increase in risk associated with assisted hatching in cycles using day 5–6 
embryos. Although previous reports of the association between assisted hatching and 
monozygotic twinning have been contradictory,7,10,14,22 recent studies9,13 indicated that 
zona pellucida manipulation during assisted hatching confers increased risk, particularly for 
cleavage-stage embryos, although the mechanism is unknown. Although there is some 
evidence that assisted hatching marginally improves clinical pregnancy rates, corresponding 
increases in live birth rates have not been documented.23 Indeed, a recent study found that 
pregnancy outcomes are not improved after the use of assisted hatching, even among 
patients with poor prognoses.24
We found that use of intracytoplasmic sperm injection was associated with decreased risk 
for monozygotic twinning in day 2–3 transfers compared with conventional IVF. Findings 
from one study are consistent with our results,13 whereas other studies found either no 
association7,9 or an increased risk for monozygotic twinning with intracytoplasmic sperm 
injection use compared with conventional IVF.10 A potential explanation for our finding is 
that use of intracytoplasmic sperm injection is a surrogate measure of the underlying 
indication for the procedure, and thus performance of procedure itself does not necessarily 
reduce the risk for monozygotic twinning. For example, if intracytoplasmic sperm injection 
were performed for poor sperm quality or prior failed fertilization, the resultant embryos 
could be of lesser quality and have lower implantation potential than embryos resulting from 
fertilization that did not require the procedure. Our findings also indicated that the presence 
of uterine factor infertility reduced the risk for monozygotic twinning in day 5–6 embryos 
perhaps reflecting a lower implantation rate among women with uterine factor.
The primary strength of our study is the use of a large national surveillance database with 
sufficient sample size to study monozygotic twinning incidence among various subgroups. 
Our study also had some limitations. National ART Surveillance System data do not include 
information on embryo quality, and we were unable to control for differences in embryo 
quality between the study and comparison groups. However, we controlled for 
cryopreservation of extra embryos, which has been shown to be a good predictor of embryo 
quality.25 Like with any observational study, participants were not randomized, and we were 
only able to adjust for patient and cycle characteristics that were available in the National 
ART Surveillance System. Finally, our findings are only generalizable to patients 
undergoing IVF in the United States.
Although we found that the rate of monozygotic twinning after single embryo transfer was 
unchanged over the study period, future increases in the use of blastocyst transfer may lead 
to elevated incidence of monozygotic twinning. Given recent increases in the use of elective 
single embryo transfer and the high proportion of blastocyst-stage embryos used during 
these transfers, rates of monozygotic twinning after single embryo transfer may increase in 
the future.26 Although the American Society for Reproductive Medicine recommends 
transfer of fewer embryos for blastocyst-compared with cleavage-stage embryos, our 
findings suggest that it may be important to consider the increased risk of monozygotic 
Kanter et al. Page 5













twinning associated with assisted hatching when deciding how many cleavage-stage 
embryos to transfer.27
The findings of this study reinforce the importance of determining types of placentation as 
early as possible for all twins, even those conceived with in vitro techniques. Monochorionic 
twins (twins that share the same placenta) carry increased risks for poor pregnancy 
outcomes, including twin–twin transfusion syndrome, twin anemia–polycythemia syndrome, 
and fetal anomalies, compared with dichorionic pregnancies. As such, high-risk care for 
monochorionic twins is important to diagnose and manage these problems should they 
occur.
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Absolute number of fresh, nondonor, single embryo transfer cycles by day of transfer, 
United States, 2003–2012. P<.05 for all linear trends.
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Trends in monozygotic twinning for fresh, non-donor, single embryo transfer cycles by day 
of transfer, United States, 2003–2012. P=.80 for Cochrane-Armitage trend test.
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Table 1
Percentage Distribution of Patient and Cycle Characteristics in Monozygotic Twin Pregnancies and Singleton 
Pregnancies After Single Embryo Transfer, United States, 2003–2012
Characteristic
Monozygotic Twin Pregnancies* 
(n=641) Singleton Pregnancies† (n=27,955) P
Maternal age (y) .37
 Younger than 30 131 (20.4) 5,258 (18.9)
 30–34 288 (44.9) 12,159 (43.5)
 35–39 172 (26.8) 8,352 (29.9)
 40 or older 50 (7.8) 2,186 (7.8)
Race or ethnicity .61
 Non-Hispanic white 284 (44.3) 13,214 (47.3)
 Non-Hispanic black 22 (3.4) 951 (3.4)
 Asian or Pacific Islander 55 (8.6) 2,106 (7.5)
 Hispanic 29 (4.5) 1,186 (4.2)
 Other race 0 39 (0.1)
 Unknown or missing 251 (39.2) 10,459 (37.4)
Infertility diagnosis
 Tubal factor 75 (11.7) 4,013 (14.4) .06
 Endometriosis 62 (9.7) 2,752 (9.8) .89
 Uterine factor 21 (3.3) 1,315 (4.7) .09
 Ovulatory disorder (polycystic ovary syndrome) 145 (22.6) 5,212 (18.6) .01
 Diminished ovarian reserve 68 (10.6) 3,745 (13.4) .04
 Male factor 219 (34.2) 10,341 (37.0) .14
 Unexplained 100 (15.6) 4,185 (15.0) .66
No. of prior pregnancies .02
 0 272 (42.5) 13,181 (47.3)
 1 or more 368 (57.5) 14,707 (52.7)
No. of prior spontaneous abortions .04
 0 451 (70.4) 20,678 (74.0)
 1 or more 190 (29.6) 7,277 (26.0)
No. of prior live births 1.00
 0 429 (67.0) 18,674 (67.0)
 1 or more 211 (33.0) 9,184 (33.0)
No. of prior ART cycles .99
 0 441 (68.8) 19,239 (68.8)
 1 or more 200 (31.2) 8,715 (31.2)
Day of transfer <.001
 2–3 162 (25.3) 9,309 (33.3)
 5–6 479 (74.7) 18,646 (66.7)
No. of oocytes retrieved .07
 1–4 91 (14.2) 4,734 (16.9)
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Characteristic
Monozygotic Twin Pregnancies* 
(n=641) Singleton Pregnancies† (n=27,955) P
 5 or more 550 (85.8) 23,221 (83.1)
Use of ICSI .02
 Did not use ICSI 222 (34.8) 8,540 (30.6)
 Used ICSI 416 (65.2) 19,366 (69.4)
Use of assisted hatching .46
 Did not use assisted hatching 465 (72.5) 20,639 (73.8)
 Used assisted hatching 176 (27.5) 7,316 (26.2)
Supernumerary embryos available and cryopreserved .21
 None 271 (42.4) 12,493 (44.9)
 1 or more cryopreserved 368 (57.6) 15,342 (55.1)
ART, assisted reproductive technology; ICSI, intracytoplasmic sperm injection.
Data are n (%) unless otherwise specified.
Missing data less than 0.50% for all variables.
*
One embryo transferred and more than one fetal heart tone reported or more than one liveborn or stillborn neonate reported.
†
One embryo transferred and one fetal heart tone reported or one liveborn or stillborn neonate reported.
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Table 2
Relative Risk of Monozygotic Twinning by Cycle Characteristics for Day 2–3 Single-Embryo Transfers, 
2003–2012
Characteristic
Comparison Group: Singleton Pregnancies
Monozygotic Twinning (%) RR (95% CI) Adjusted RR* (95% CI)
Maternal age (y)
 Younger than 30 2.2 1.64 (1.02–2.63) 1.68 (1.05–2.71)
 30–34 1.3 Reference Reference
 35–39 2.0 1.46 (1.03–2.17) 1.33 (0.90–1.97)
 40 or older 1.6 1.18 (0.70–1.99) 0.99 (0.56–1.76)
Infertility diagnosis
 Tubal factor 1.4 0.77 (0.48–1.22) 0.68 (0.42–1.09)
 Endometriosis 1.9 1.13 (0.72–1.78) 1.05 (0.66–1.67)
 Uterine factor 2.0 1.18 (0.60–2.29) 1.14 (0.59–2.21)
 Ovulatory disorder 1.9 1.13 (0.74–1.74) 1.05 (0.67–1.65)
 Diminished ovarian reserve 1.6 0.89 (0.62–1.29) 0.77 (0.51–1.16)
 Male factor 1.5 0.83 (0.60–1.15) 0.98 (0.68–1.42)
No. of prior pregnancies
 0 1.7 Reference Reference
 1 or more 1.8 1.07 (0.79–1.46) 1.15 (0.83–1.59)
No. of prior ART cycles
 0 1.8 Reference Reference
 1 or more 1.5 0.84 (0.61–1.15) 0.81 (0.58–1.13)
No. of oocytes retrieved
 1–4 1.9 Reference Reference
 5 or more 1.6 0.85 (0.63–1.15) 0.80 (0.56–1.13)
Use of ICSI
 Did not use ICSI 2.2 Reference Reference
 Used ICSI 1.5 0.69 (0.51–0.94) 0.60 (0.42–0.85)
Use of assisted hatching
 Did not use assisted hatching 1.2 Reference Reference
 Used assisted hatching 2.3 1.81 (1.33–2.48) 2.16 (1.53–3.06)
Supernumerary embryos available and cryopreserved
 None 1.7 Reference Reference
 1 or more cryopreserved 1.7 1.00 (0.69–1.45) 1.19 (0.78–1.82)
RR, relative risk; CI, confidence interval; ART, assisted reproductive technology; ICSI, intracytoplasmic sperm injection.
*
Adjusted for all characteristics in the table.
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Table 3
Relative Risk of Monozygotic Twinning by Cycle Characteristics for Day 5–6 Single Embryo Transfers, 
2003–2012
Characteristic
Comparison Group: Singleton Pregnancies
Monozygotic Twinning (%) RR (95% CI) Adjusted RR* (95% CI)
Maternal age (y)
 Younger than 30 2.5 0.93 (0.74–1.17) 0.97 (0.77–1.23)
 30–34 2.7 Reference Reference
 35–39 2.1 0.76 (0.61–0.96) 0.73 (0.58–0.93)
 40 or older 3.1 1.17 (0.80–1.69) 1.17 (0.73–1.79)
Infertility diagnosis
 Tubal factor 2.1 0.82 (0.62–1.08) 0.81 (0.61–1.08)
 Endometriosis 2.4 0.95 (0.70–1.31) 1.00 (0.72–1.37)
 Uterine factor 1.4 0.53 (0.30–0.94) 0.50 (0.28–0.90)
 Ovulatory disorder 3.0 1.13 (0.74–1.74) 1.17 (0.95–1.45)
 Diminished ovarian reserve 2.1 0.83 (0.58–1.19) 0.78 (0.53–1.16)
 Male factor 2.4 0.91 (0.76–1.10) 0.97 (0.79–1.20)
No. of prior pregnancies
 0 2.2 Reference Reference
 1 or more 2.8 1.25 (1.04–1.49) 1.26 (1.03–1.53)
No. of prior ART cycles
 0 2.4 Reference Reference
 1 or more 2.8 1.16 (0.95–1.40) 1.12 (0.91–1.38)
No. of oocytes retrieved
 1–4 2.0 Reference Reference
 5 or more 2.5 1.30 (0.79–2.13) 1.25 (0.74–2.10)
Use of ICSI
 Did not use ICSI 2.7 Reference Reference
 Used ICSI 2.4 0.87 (0.72–1.05) 0.88 (0.71–1.09)
Use of assisted hatching
 Did not use assisted hatching 2.5 Reference Reference
 Used assisted hatching 2.5 0.99 (0.78–1.26) 1.03 (0.80–1.33)
Supernumerary embryos available and cryopreserved
 None 2.7 Reference Reference
 1 or more cryopreserved 2.4 0.91 (0.75–1.10) 0.91 (0.73–1.12)
RR, relative risk; CI, confidence interval; ART, assisted reproductive technology; ICSI, intracytoplasmic sperm injection.
*
Adjusted for all characteristics in the table.
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